Here is the Merrimack Pharma's pipeline info for MM-121:
MM-121 (Signaling Inhibitor)
- Indication:
- Description:
- Target
- NSCLC, Breast Cancer, Ovarian Cancer
- Monoclonal Antibody
- ErbB3
MM-121/SAR256212 is a fully human monocolonal antibody that targets the HER3 receptor. Merrimack’s Network Biology approach identified HER3 as a critical tumorigenic node in several types of cancer.